Newsroom
Our latest developments
Orca Bio’s announcements and press releases
Orca Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
ViewOrca Bio Presents Encouraging Interim Clinical Data on Orca-Q in Haploidentical Allogeneic Hematopoietic Stem Cell Transplants at 64th ASH Annual Meeting
ViewOrca Bio Presents Data Demonstrating its Lead Investigational High-Precision Cell Therapy Orca-T Significantly Improved Relapse-Free Survival at 64th Annual Meeting
ViewOrca Bio to Present Four Abstracts at the 64th American Society of Hematology Annual Meeting, Including Updated Relapse-Free Survival Data with Orca-T and the First Clinical Data for Orca-Q
ViewOrca Bio Expands Manufacturing Capabilities to Develop and Commercialize its Precision Cell Therapies
ViewOrca Bio Announces the Precision-T Phase 3 Study is Open and Enrolling Patients at Transplant Centers Across the U.S.
ViewOrca Bio to Present New Clinical Data on Orca-T at the European Hematology Association 2022 Congress
View